Cite
HARVARD Citation
Davies, M. et al. (n.d.). A Randomized Controlled, Treat-to-Target Study Evaluating the Efficacy and Safety of Insulin Glargine 300 U/mL (Gla-300) Administered Using Either Device-Supported or Routine Titration in People With Type 2 Diabetes. Journal of diabetes science and technology. pp. 881-889. [Online].